Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Ertapenem in Critically Ill Patients on CVVHD
NCT00877370Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Feb 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ertapenem in bacterial infection, sponsored by University of Michigan. Primary endpoint: Ertapenem Transmembrane Clearance by Continuous Hemodialysis at 24 hours. Started Feb 2009; status: completed.
02
Drugs
ertapenem
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT00877370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00877370.